ArticleCureus2026
Novel Ultrasound-Guided Bilateral Simultaneous Hydrodissection of the Cervical Sympathetic Chain and Vagus Nerves: A Detailed Technical Description With Anatomical Correlation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The vagus nerve and cervical sympathetic chain regulate autonomic function and are implicated in chronic pain and post-viral autonomic syndromes. Hydrodissection with 5% dextrose is established for peripheral nerves, but simultaneous ultrasound-guided hydrodissection of both cervical autonomic nerves has not been described. We describe a reproducible ultrasound-guided technique for bilateral simultaneous hydrodissection of the cervical sympathetic chain and vagus nerves using 5% dextrose without local anesthetic. The procedure uses a high-frequency linear transducer at C6-C7 and an in-plane lateral 25-gauge needle approach, performing the deeper sympathetic chain hydrodissection first (prevertebral fascia superficial to the longus colli), followed by vagus nerve hydrodissection within the carotid sheath. Injection is performed slowly (12-18 minutes per side) to permit full delivery and patient comfort. We report procedural outcomes in 10 patients (30 sessions) treated for post-COVID-related autonomic dysfunction. All procedures were completed successfully. Total injectate was 60 mL of 5% dextrose per side (approximately 30 mL for the sympathetic chain and 30 mL for the vagus nerve). The deep-to-superficial sequence preserved sonographic visualization and avoided air-bubble artifact. No procedural complications occurred (including bradycardia, hypotension, voice changes, dysphagia, hematoma, or infection). At a minimum 12-month follow-up, patients maintained clinical improvement without additional interventions. Ultrasound-guided bilateral simultaneous hydrodissection of the cervical sympathetic chain and vagus nerves with 5% dextrose is technically feasible and well tolerated. A deep-to-superficial injection sequence and very slow administration optimize visualization and delivery. Detailed clinical outcomes are presented separately.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.